Overview

Efficacy of Rostafuroxin in the Treatment of Essential Hypertension

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify the efficacy of Rostafuroxin in the treatment of essential hypertension and to determine the best effective dose to be administered in the general hypertensive population and in a subset of this population in which genetic patterns could be involved in the etiology of essential hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
sigma-tau i.f.r. S.p.A.